Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland
An Infectious Diseases Physician and Clinical Microbiologist, Prof Paul Griffin was appointed as the Director of Infectious Diseases at Mater Health Services in 2013, and most recently, to his conjoint role as Head of the Mater Clinical Unit for the University of Queensland School of Medicine.
Prof Griffin is an accomplished clinical trial investigator, having fulfilled the role of Principal Investigator in over 150 clinical trials, particularly in Infectious Diseases including 8 COVID-19 vaccines. Despite an already demanding role at the Mater, Prof Griffin continues as a member of the AMA Queensland Council 2023-2024, and as board member and scientific advisory board member of the Immunisation Coalition, with active interest in vaccine education and advocacy, becoming a trusted media authority and spokesperson across the nation during the COVID-19 pandemic.
Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time. Additionally COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed
A high index of suspicion based on vaccination status, travel and exposure history will help raise a red flag- GPs are once again at the forefront of identifying, treating and ensuring that we commence the appropriate public health interventions.
This mosquito-transmitted disease has already killed a handful of people, and is likely to become more common- an effective vaccine will soon be made widely available to those at risk.
In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).
Learn how to educate your older patients on how to stay protected from COVID-19, as well as vaccination tips, the role of antivirals in reducing severe COVID infection, managing risks for vulnerable patients, and practical prevention strategies in this latest podcast
In this short video, Prof Paul Griffin provides an update on respiratory viruses, emphasising the critical need to increase vaccination uptake, particularly for COVID-19, Influenza and Respiratory syncytial virus (RSV), and the need for healthcare professionals to actively promote and facilitate co-administration.
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist Prof Paul Griffin provides an update on the intranasal flu vaccine now available and provides a detailed demonstration of how to use the device (8 mins).
Save 50% on all seminars. Hurry, sale ends Dec 31!
You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!